0001564590-21-025721 | 10-Q | XBRL Viewer

Registered Offering and Warrants

12.	Registered Offering and Warrants

The Company has outstanding warrants as described in the Annual Financial Statements. Warrants outstanding at March 31, 2021, and related activity for the three months ended March 31, 2021 is as follows (reflects the number of Class 2 common stock as if the warrants were converted to Class 2 common stock):

Description

Classification

Exercise

price

Expiration

date

Balance

December 31,

2020

Issued

Exercised

Balance

March 31,

2021

Warrants

Liability

5.95

March 17, 2025

19,000,000

—

12,791,000

6,209,000

Total

19,000,000

—

12,791,000

6,209,000

During the quarter ended March 31, 2021 12,791,000 warrants were exercised by warrant holders resulting in cash proceeds to the Company of $76,106.

The Company estimated the fair value of the Warrant liability at March 31, 2021 using the Monte Carlo pricing model (Level 3) with the following weighted-average assumptions:

Risk-free interest rate		0.92	%
Expected volatility		100	%
Expected term	4.5 years
Expected dividend yield		0	%
Strike price	$	5.95
Fair value of common stock	$	22.73
Discount due to exercise restrictions		0	%

Expected volatility is based on the historical volatility of the Company's common stock since its initial public offering in 2018.

Stockholders' Equity

3 Months Ended

Mar. 31, 2021

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Stockholders' Equity

13.	Stockholders’ Equity

Common and preferred stock

The Company’s certificate of incorporation authorized the Company to issue the following classes of shares with the following par value and voting rights as of March 31, 2021. The liquidation and dividend rights are identical among Class 1 common stock and Class 2 common stock, and all classes of common stock share equally in the Company’s earnings and losses.

	Par Value		Authorized		Voting Rights
Class 1 common stock	$	0.0001		233,333,333	10 votes for each share
Class 2 common stock	$	0.0001		500,000,000	1 vote for each share
Preferred stock	$	0.0001		10,000,000	N/A

During the three months ended March 31, 2021, the Company issued 6,254,980 shares of Class 2 common stock for gross proceeds of $159,213 under its at-the-market equity offering program (2020 - $27,579). Transaction costs of $3,184 were recorded net against the allocated gross proceeds in additional paid-in-capital. As described in the Annual Financial Statements, the warrants’ anti-dilution price protection features allow, for the period the warrants are outstanding, the Company to only issue up to $20,000 in aggregate gross proceeds under the Company’s at-the-market offering program at prices less than the exercise price of the warrants, and in no event more than $6,000 per quarter, at prices below the exercise price of the warrants, without triggering the warrant’s anti-dilution price protection features.

The Company’s future ability to pay cash dividends on Class 2 common stock is limited by the terms of the Senior Facility and cannot be paid without the consent of the lender.

Stock-Based Compensation

3 Months Ended

Mar. 31, 2021

Stock-Based Compensation

14.	Stock-based Compensation

Original Stock Option Plan

Certain employees of the Company participate in the equity-based compensation plan of Privateer Holdings, Inc. (the “Original Plan”) under the terms and valuation method detailed in our annual financial statements. For the three months ended March 31, 2021, the total stock-based compensation expense associated with the Original Plan was $57 (2020 – $162). As of March 31, 2021 the total remaining unrecognized stock-based compensation expense related to non-vested stock options under the Original Plan amounted to $193 which will be recognized over the weighted-average remaining requisite service period of approximately 0.6 years.

Stock option activity under the Original Plan is as follows:

	Stock options			Weighted- average exercise price		Weighted- average remaining contractual term (years)		Aggregate intrinsic value
Balance December 31, 2020		1,789,750		$	3.62		3.8	$	25,077
Exercised		(757,318	)		3.17
Forfeited		—			—
Cancelled		(80	)		4.72
Balance March 31, 2021		1,032,352		$	3.93		4.3	$	13,660
Vested and expected to vest, March 31, 2021		986,020		$	3.91		4.3	$	13,618
Vested and exercisable, March 31, 2021		945,951		$	3.72		4.2	$	13,200

No stock options were granted under the Original Plan during the three months ended March 31, 2021 and March 31, 2020. The total fair value of stock options vested as of March 31, 2021 was $61 (2020 – $169).

New Stock Option and Restricted Stock Unit Plan

The Company adopted the 2018 Equity Incentive Plan (the “2018 EIP”) as amended and approved by stockholders in May 2018 under the terms and valuation methods detailed in the Annual Financial Statements. The number of shares of Class 2 common stock reserved for issuance under the 2018 EIP automatically increases on January 1 of each calendar year, for a period of not more than ten years, starting on January 1, 2019 and ending on and including January 1, 2027, in an amount equal to 4% of the total number of shares of our common stock outstanding on December 31 of the prior calendar year, or a lesser number of shares determined by our Board of Directors. The shares reserved include only the outstanding shares related to stock options and RSUs and excludes stock options outstanding under the Original Plan. The number of shares reserved for issuance under the 2018 EIP is 23,375,665, effective as of January 1, 2021 (December 31, 2020 – 17,037,421). For the three months ended March 31, 2021, total stock-based compensation expense associated with the 2018 EIP was $7,084 (2020 – $7,515). As of March 31, 2021, the total remaining unrecognized stock-based compensation expense related to non-vested stock options and restricted stock units (“RSUs”) under the 2018 EIP amounted to $29,883 which will be recognized over the weighted average remaining requisite service period of approximately 1.63 years.

Stock option and RSU activity under the 2018 EIP are as follows:

Time-based stock option activity

	Stock options			Weighted- average exercise price		Weighted- average remaining contractual term (years)		Aggregate intrinsic value
Balance December 31, 2020		3,909,559		$	15.25		7.4	$	1,700,194
Granted		—			—
Exercised		(471,211	)		7.76
Forfeited		(33,291	)		8.46
Cancelled		(36,414	)		42.61
Balance March 31, 2021		3,368,643		$	16.02		7.2	$	43,421
Vested and expected to vest, March 31, 2021		3,360,695		$	15.87		7.2	$	43,213
Vested and exercisable, March 31, 2021		2,902,957		$	13.77		7.2	$	38,916

The weighted-average fair values of stock options granted during the three months ended March 31, 2021 was $0 per share (2020 – $0). The total fair value of stock options vested in 2021 was $2,547 (2020 – $25,426).

Time-based RSU activity

	Time-based RSUs			Weighted-average grant-date fair value per share
Non-vested December 31, 2020		1,884,390		$	15.22
Granted		350,311			20.02
Vested		(289,388	)		15.59
Forfeited		(170,641	)		11.84
Non-vested March 31, 2021		1,774,672		$	16.33

During the three months ended March 31, 2021, 350,311 (2020 – 752,283) time-based RSUs were granted. During the three months ended March 31, 2021, 289,388 (2020 – 154,642) time-based RSUs vested.

Performance-based RSUs activity

	Performance-based RSUs			Weighted-average grant-date fair value per share
Non-vested December 31, 2020		540,836		$	7.13
Vested		(341,543	)		7.18
Non-vested March 31, 2021		199,293		$	7.05

No performance-based RSUs were granted during the three months ended March 31, 2021 (2020 – none). During the three months ended March 31, 2021, 341,543 (2020 – 53,125) performance-based RSUs vested .

Accumulated Other Comprehensive (Loss) Income (AOCI)

3 Months Ended

Mar. 31, 2021

Accumulated Other Comprehensive (Loss) Income ("AOCI")

15.	Accumulated Other Comprehensive (Loss) Income (“AOCI”)

The component of AOCI, net of tax, was as follows:

	Foreign Currency Translation Adjustments
Balance as at December 31, 2020	$	8,205
Other comprehensive loss:
Change in foreign currency translation		3,753
Balance as at March 31, 2021	$	11,958

Commitments and Contingencies

3 Months Ended

Mar. 31, 2021

Commitments And Contingencies Disclosure [Abstract]

Commitments and Contingencies

16.	Commitments and Contingencies

Legal proceedings

In the normal course of business, the Company may become involved in legal disputes regarding various litigation matters. The Company records a loss contingency if the information available indicates that it is probable that a liability has been incurred at the date of the financial statements and the amount of loss can be reasonably estimated. As of March 31, 2021, in the opinion of management, no claims meet the criteria to record a loss contingency.

Lease commitments

The Company leases various facilities, under non-cancelable finance and operating leases, which expire at various dates through September 2027.

Maturities of lease liabilities:

Year ending December 31,	Operating Leases		Finance Leases
2021 (remaining nine months)	$	2,861	$	893
2022		3,498		6,165
2023		3,351		12,438
2024		2,758		—
2025		2,179		—
Thereafter		6,428		—
Total minimum lease payments		21,075		19,496
Less: amounts related to interest payments		3,260		3,902
Present value of minimum lease payments		17,815		15,594
Less: current accrued lease obligation		2,888		—
Obligations recognized	$	14,927	$	15,594

Purchase commitments

The following table reflects the Company’s future non-cancellable minimum purchase commitments for inventory as of March 31, 2021:

Total

2021

(remaining

nine months)

2022

2023

2024

2025

Thereafter

Purchase commitments

17,359

—

Total

17,359

—

Due to the termination of a supply agreement, the Company removed $59,700 of purchase commitments from its commitments and contingencies as of March 31, 2021.

In 2018, the Company signed an agreement with Rose Lifescience Inc. (“Rose”) for distribution and marketing of product in Quebec in exchange for a minimum fee of $384 per annum for an initial term of five years. In September 2020, the Company signed an amendment to this agreement under which the Company is no longer obligated to purchase product from Rose nor pay the minimum fee. The Company will pay Rose a compensation fee based on net revenue sold in Quebec for an estimated compensation fee of approximately $8,000 through 2023. As there is no firm commission fee commitment, it is excluded from the above schedule. Compensation fee expense is recorded as incurred.

In 2018, the Company entered into a Product and Trademark License Agreement with Docklight LLC, a related party (refer to Note 20), to use certain intellectual property rights in exchange for payment of royalty depending upon specified percentage of licensed product net sales, with a minimum royalty of $493 per quarter. As the purchase commitment is an undeterminable variable amount, it is excluded from the above schedule.

Other commitments

The Company has payments on the convertible notes (refer to Note 10), the Senior Facility (refer to Note 11), ABG finance liability and Portugal construction purchase commitments as follows:

	Total		2021 (remaining nine months)		2022		2023		2024		2025		Thereafter
Convertible notes, principal and interest	$	319,535	$	13,893	$	13,893	$	291,749	$	—	$	—	$	—
Senior Facility, principal and interest		56,533		4,029		52,504		—		—		—		—
ABG finance liability		7,500		1,500		1,500		1,500		1,500		1,500		—
Portugal construction commitments		2,778		2,778		—		—		—		—		—
Total	$	386,346	$	22,200	$	67,897	$	293,249	$	1,500	$	1,500	$	—

Revenue from Contracts with Customers

3 Months Ended

Mar. 31, 2021

Revenue From Contract With Customer [Abstract]

Revenue from Contract with Customers

17.	Revenue from Contracts with Customers

The Company reports two segments: cannabis and hemp, in accordance with ASC 280 Segment Reporting. The Company generates revenues from the cannabis and hemp segments through contracts with customers, each with a single performance obligation, being the sale of products. The Company determines that revenue information disclosed in business segment information in Note 23 disaggregates revenue into categories that depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.

For certain long-term arrangements, the Company has performance obligations for goods it has not yet delivered. For these arrangements, the Company does not have a right to bill for the undelivered goods. The Company has determined that any unbilled consideration relates entirely to the value of undelivered goods. Accordingly, the Company has not recognized revenue, and has elected not to disclose amounts, related to these undelivered goods. As of March 31, 2021 and December 31, 2020, other than accounts receivable, net of allowance for doubtful debts, the Company has no contract balances in the balance sheets.

The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-URI http://asc.fasb.org/topic&trid=49130388

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

General And Administrative Expense [Abstract]

General and Administrative Expenses

3 Months Ended

Mar. 31, 2021

General and Administrative Expenses

18.	General and Administrative Expenses

General and administrative expenses are comprised of the following items:

	Three months ended March 31,
	2021		2020
Other expenses	$	7,613	$	6,848
Salaries and benefits		7,013		7,296
Stock-based compensation expenses		6,493		7,138
Professional fees		3,577		4,521
Credit loss expenses		742		46
Loss on disposal of property and equipment		83		457
Travel expenses		66		963
Total	$	25,587	$	27,269

Supplemental Cash Flow Information

3 Months Ended

Mar. 31, 2021

Supplemental Cash Flow Information [Abstract]

Supplemental Cash Flow Information

19.	Supplemental Cash Flow Information

	Three months ended March 31,
	2021		2020
Cash paid for income taxes	$	103	$	—
Cash paid for interest		912		704

	Three months ended March 31,
	2021		2020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	994	$	854
Operating cash flows from finance leases		264		142
Financing cash flows from finance leases		—		105
Non-cash additions to Right-of-use assets and lease liabilities
Operating leases		33		423

Related Party Transactions

3 Months Ended

Mar. 31, 2021

Related Party Transactions

20.	Related Party Transactions

In the normal course of business, the Company enters into related party transactions with certain entities under common control and joint ventures as described in the Annual Financial Statements and detailed below.

Leafly Holdings, Inc. (“Leafly”)

The Company has a series of agreements with Leafly providing for, among other things, data licensing, advertising and marketing activities. During the three months ended March 31, 2021, no operational expenses was recorded within general and administrative expenses in the statements of net loss and comprehensive loss (2020 - $129).

Docklight LLC (“Docklight”)

The Company pays Docklight a royalty fee pursuant to a brand licensing agreement which provides the Company with exclusive rights in Canada for the use of certain adult-use brands. During the three months ended March 31, 2021, royalty fees of $493 were recorded within general and administrative expenses in the statements of net loss and comprehensive loss (2020 - $221). Refer to Note 16 for purchase commitments with Docklight.

Fluent and Cannfections

The Company has joint venture arrangements with a 50% ownership and voting interest in each Fluent and Cannfections. Refer to Note 4 for details over transactions with these entities for the three months ended March 31, 2021.

Financial Instruments

3 Months Ended

Mar. 31, 2021

Investments All Other Investments [Abstract]

Financial Instruments

21.	Financial Instruments

Credit risk

Credit risk is the risk of financial loss to the Company if a customer or counterparty to a financial instrument fails to meet its contractual obligations, and arises principally from the Company’s cash and cash equivalents and accounts receivable.

The Company’s cash and cash equivalents are deposited in major financial institutions in Canada, Australia, Portugal, Germany and the United States. To date, the Company has not experienced any losses on its cash deposits. Accounts receivable are unsecured and the Company does not require collateral from its customers.

The Company is also exposed to credit risk from the potential default by any of its counterparties on its financial assets.

The Company evaluates the collectability of its accounts receivable and provides an allowance for credit losses as necessary (refer to Note 5).

Due to the uncertainties associated with COVID-19, the Company may be unable to accurately predict the creditworthiness of its counterparties and their ability to meet their obligations. This may result in unforeseen additional credit losses.

Foreign currency risk

The Company conducts its business in several countries and in a variety of currencies, the most significant of which are the Canadian dollar and the Euro. Consequently, the Company is exposed to foreign currency risk. A significant portion of the Company’s assets, liabilities, revenue, and expenses are denominated in Canadian dollars. A 10% change in the exchange rates for the Canadian dollar would affect the carrying value of net assets by approximately $47,220 as of March 31, 2021, with a corresponding impact to accumulated other comprehensive (loss) income. The Company is also exposed to risk related to changes in the value of the Euro due to its construction commitments in Portugal.

Interest rate risk

The Company’s exposure to changes in interest rates relates primarily to the Company’s outsanding debt. The Company is exposed to changes to the Canadian prime rate as the Senior Facility bears interest based on the Canadian prime rate plus 8.05%. The convertible notes bear interest at a fixed rate of 5% and are not publicly traded and is therefore are not affected by changes in the market interest rates. A 1% change in the Canadian prime rate would have an impact of $134 to the statements of net loss and comprehensive loss for the three months ended March 31, 2021.

Liquidity risk

The Company’s objective is to have sufficient liquidity to meet its liabilities when due. The Company monitors its cash balances and cash flows generated from operations to meet its requirements. As of March 31, 2021, the most significant financial liabilities are accounts payable, accrued expenses and other current liabilities, convertible notes and the Senior Facility.

Equity price risks

As of March 31, 2021, we held long-term equity investments at fair value and equity investments under the measurement alternative. These investment in equities were acquired as part of our strategic transactions. Accordingly, the changes in fair values of investment in equities measured at fair value or under the measurement alternative are recognized through other expense (income), net in the statements of net loss and comprehensive loss. Based on the fair value of investment in equities held as of March 31, 2021, a hypothetical decrease of 10% in the prices for these companies would reduce the fair values of the investments and result in unrealized loss recorded in other expense (income), net by $1,132. Similarly, based on the fair value of our warrant liability as of March 31, 2021, a hypothetical increase of 10% in the price for our common stock would increase the change in fair value of warrant liability by $12,290.

Fair Value Measurement

3 Months Ended

Mar. 31, 2021

Fair Value Disclosures [Abstract]

Fair Value Measurement

22.	Fair Value Measurement

The Company complies with ASC 820, Fair Value Measurements, for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. In general, fair values determined by Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities. Fair values determined by Level 2 inputs utilize data points that are observable such as quoted prices, interest rates and yield curves. Fair values determined by Level 3 inputs are unobservable data points for the asset or liability, and includes situations where there is little, if any, market activity for the asset or liability.

The following tables present information about the Company’s assets that are measured at fair value on a recurring basis as of March 31, 2021 and December 31, 2020 and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value:

	Quoted prices
	in active
	markets for		Other			Significant
	identical		observable			unobservable
	assets		inputs			inputs
	(Level 1)		(Level 2)			(Level 3)			Total
March 31, 2021
Equity investments measured at fair value	$	633	$	—		$	—		$	633
Warrant liability		—		—			(122,804	)		(122,804	)
Convertible Debt		—		(269,223	)		—			(269,223	)
Total recurring fair value measurements	$	633	$	(269,223	)	$	(122,804	)	$	(391,394	)

	Quoted prices
	in active
	markets for		Other			Significant
	identical		observable			unobservable
	assets		inputs			inputs
	(Level 1)		(Level 2)			(Level 3)			Total
December 31, 2020
Investments
Equity investments measured at fair value	$	477	$	—		$	—		$	477
Debt securities classified as available-for-sale		—		—			2,500			2,500
Warrant liability		—		—			(120,647	)		(120,647	)
Convertible Debt		—		(239,652	)		—			(239,652	)
Total recurring fair value measurements	$	477	$	(239,652	)	$	(118,147	)	$	(357,322	)

Items measured at fair value on a recurring basis

The Company’s financial assets and liabilities required to be measured on a recurring basis are its equity investments measured at fair value, convertible debt and warrant liability.

Equity investments recorded at fair value: The estimated fair value is determined using quoted market prices, broker or dealer quotations or discounted cash flows. These are classified as Level 1.

Warrant liability: The warrants associated with the warrant liability are classified as Level 3 derivatives. Consequently, the estimated fair value of the warrant liability is determined using the Monte Carlo pricing model (refer to Note 12). Until the warrants are exercised, expire, or other facts and circumstances lead the warrant liability to be reclassified to stockholders’ equity, the warrant liability (which relates to warrants to purchase shares of Class 2 common stock) is marked-to-market each reporting period with the change in fair value recorded in change in fair value of warrant liability. Any significant adjustments to the unobservable inputs disclosed in the table below would have a direct impact on the fair value of the warrant liability.

Convertible Debt: This instrument is held at amortized cost. The estimated fair value is determined using quoted market prices near the reporting date and is classified as Level 2.

The opening balances of assets and liabilities categorized within Level 3 of the fair value hierarchy measured at fair value on a recurring basis are reconciled to the closing balances as follows:

	Debt securities classified as available-for- sale			Warrant liability
Opening balance as at December 31, 2020	$	2,500		$	(120,647	)
Additions and settlements
Additions		—			—
Exercise		—			—
Settlements		(2,500	)		81,223
Interest expenses, net		—			—
Change in fair value		—			(83,380	)
Closing balance as at March 31, 2021	$	—		$	(122,804	)

	Quantitative information about Level 3 fair value measurements
	Fair value at March 31, 2021			Valuation technique	Unobservable input	Range (weighted average)

Warrant liability	$	(122,804	)	Monte Carlo	Volatility	100%
					Expected life	0.2 years to 4.5 years (2.1 years)

Items measured at fair value on a non-recurring basis

The Company's prepayments and other current assets, long lived assets, including property and equipment, goodwill and intangible assets are measured at fair value when there is an indicator of impairment and are recorded at fair value only when an impairment charge is recognized.

The estimated fair value of cash and cash equivalents, accounts receivable, net, accounts payable, accrued expenses and other current liabilities and Senior Facility at March 31, 2021 (December 31, 2020 – the fair value of all aforementioned) approximate their carrying value.

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

Business Segment Information

Business Segment Information

3 Months Ended

Mar. 31, 2021

Segment Reporting [Abstract]

23.	Business Segment Information

The Company has two operating segments based on major product categories: cannabis and hemp. These operating segments are also the Company’s reportable segments.

The cannabis segment cultivates, processes and distributes medical and adult-use cannabis products in a variety of formats, as well as related accessories, on a global basis. The hemp segment processes and distributes a diverse portfolio of hemp-based natural and organic food and wellness products on a global basis.

The results of each segment are regularly reviewed by the Company’s Chief Executive Officer, who is the Company’s chief operating decision maker, to assess the performance of the segment and make decisions regarding the allocation of resources. The Company’s chief operating decision maker uses revenue and gross profit as the measure of segment profit or loss. The accounting policies of each segment are the same as those set out under the summary of significant accounting policies in Note 1. There are no intersegment sales or transfers.

	Three months ended March 31,
	2021				2020
	Revenue		Gross profit		Revenue		Gross profit
Cannabis	$	31,386	$	9,343	$	30,776	$	2,926
Hemp	$	16,635	$	4,160	$	21,326	$	7,944
Total	$	48,021	$	13,503	$	52,102	$	10,870

No asset information is provided for the segments because the Company’s chief operating decision maker does not review this information by segment on a regular basis.

Total revenue and gross profit for the reportable segments is equal to the Company’s consolidated revenue and gross profit.

	Three months ended March 31,
	2021			2020
Gross profit for the segments	$	13,503		$	10,870
General and administrative expenses		25,587			27,269
Sales and marketing expenses		9,739			18,326
Research and development expenses		1,202			1,347
Depreciation and amortization expenses		3,498			3,591
Impairment of assets		—			29,839
Loss from equity method investments		1,787			1,748
Litigation settlement		45,000			—
Foreign exchange (gain) loss, net		(699	)		28,069
Change in fair value of warrant liability		263,201			71,978
Interest expenses, net		6,916			9,146
Other expense (income), net		(1,516	)		4,651
Loss before income taxes	$	(341,212	)	$	(185,094	)

Sources of revenue were as follows:

	Three months ended March 31,
	2021		2020
Dried cannabis	$	21,086	$	19,696
Cannabis extracts		10,270		10,545
Hemp products		16,635		21,326
Accessories and other		30		535
Total	$	48,021	$	52,102

Channels of revenue were as follows:

	Three months ended March 31,
	2021		2020
Cannabis
Adult-use	$	19,440	$	20,919
Canada - medical		3,217		4,051
International - medical		8,600		5,806
Bulk		129		—
Total Cannabis revenue	$	31,386	$	30,776
Hemp		16,635		21,326
Total	$	48,021	$	52,102

Revenue attributed to geographic region based on the location of the customer was as follows:

	Three months ended March 31,
	2021		2020
Canada	$	27,195	$	29,488
United States		11,043		16,530
Other countries		9,783		6,084
Total	$	48,021	$	52,102

Revenue includes excise duties of $4,646 for the three months ended March 31, 2021 (2020: $4,972).

Long-lived assets consisting of property and equipment, net of accumulated depreciation, attributed to geographic regions based on their physical location were as follows:

	March 31, 2021		December 31, 2020
Canada	$	122,182	$	122,328
Portugal		69,704		71,988
United States		5,830		5,182
Other countries		55		61
Total	$	197,771	$	199,559

Major customers

One customer, in the Cannabis segment, accounted for 20% of revenue for the three months ended March 31, 2021. One customer, in the Hemp segment, accounted for 11% of revenue for the three months ended March 31, 2021. Two customers, in the Cannabis segment, accounted for 16% and 13% of revenue, respectively, for the three months ended March 31, 2020. One customer, in the Hemp segment, accounted for 26% of revenue for the three months ended March 31, 2020.

Two customers accounted for 18% and 11%, respectively, of the Company’s accounts receivable balance as of March 31, 2021. Three customers accounted for 17%, 16% and 11%, respectively, of the Company’s accounts receivable balance as of December 31, 2020.

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-URI http://asc.fasb.org/topic&trid=2134510

Description of the Business

Subsequent Events

3 Months Ended

Mar. 31, 2021

Subsequent Events [Abstract]

Subsequent Events

24.	Subsequent Events

A cannabinoid supplier (“supplier”) to Tilray, and Tilray had been engaged in binding arbitration, which commenced in March 2020 and related to a supply agreement dispute between the parties. On April 29, 2021, the parties mutually agreed to settle this matter. Pursuant to a settlement agreement and release, Tilray (i) paid $20,000 in cash and $5,000 in Class 2 Common Stock to the supplier on April 29, 2021, and (ii) agreed to pay either $15,000 in Class 2 Common Stock or $20,000 in cash, depending on certain circumstances, to the supplier within nine months of the settlement date, in each case subject to certain upward adjustments based on the trading price and resale registration status of the Class 2 Common Stock. The parties also agreed to, among other things, withdraw

from the arbitration proceeding and to release the other party from any and all claims arising out of or relating to the arbitration or the supply agreement. As of March 31, 2021, the Company recorded the litigation settlement expense in its statement of net loss and comprehensive loss to reflect the outcome of this settlement. The litigation liability is payable in a combination of cash and shares of the Company’s class 2 common stock. The initial payments made on April 29, 2021 are reflected in accounts payable and the remaining future payment is reflected in accrued expenses. The Company also removed $59,700 of purchase commitments (refer to Note 16) from its commitments and contingencies as of March 31, 2021.

On April 25, 2021, the Company notified its senior secure credit facility lender that it intends to (i) terminate the commitments under the Senior Facility, and (ii) repay all outstanding loans and other obligations under the Senior Facility. On May 4, 2021, the Company repaid in full all outstanding indebtedness under its Senior Facility agreement. The Senior Facility and related security interests were terminated in conjunction with the repayment in full of $52,069 (C$64,000) of principal, as well as accrued and unpaid interest and fees of $494 (C$610), plus a prior notice prepayment fee of $1,070 (C$1,320).

As disclosed previously, on April 30, 2021 the Arrangement with Aphria was completed (refer to Note 1 for additional information regarding the Arrangement) and we paid the financial advisor transaction fee of $9,200.

Summary of Significant Accounting Policies (Policies)

3 Months Ended

Mar. 31, 2021

Accounting Policies [Abstract]

Description of the business

Basis of Presentation and Going Concern

Basis of presentation and going concern

Reclassifications

The Company reclassified previously disclosed amounts related to inventory valuation adjustments and stock-based compensation expenses to conform with the disclosures as of March 31, 2021.

For the three months

ended March 31, 2020

Inventory valuation adjustment no longer disclosed separately from cost of sales

4,044

	For the three months ended March 31, 2020
General and administrative expenses	$	7,138
Sales and marketing expenses		450
Research and development expenses		89

Net Loss Per Share

Net loss per share

New Accounting Pronouncements Not Yet Adopted

New accounting pronouncements not yet adopted

Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2021

Accounting Policies [Abstract]

Schedule of Inventory Valuation Adjustments Included in Cost of Sales

For the three months

ended March 31, 2020

Inventory valuation adjustment no longer disclosed separately from cost of sales

4,044

Summary of Reclassifications of Stock-Based Compensation Expenses

	For the three months ended March 31, 2020
General and administrative expenses	$	7,138
Sales and marketing expenses		450
Research and development expenses		89

Inventory (Tables)

3 Months Ended

Mar. 31, 2021

Inventory Disclosure [Abstract]

Schedule of Inventory

Inventory is comprised of the following items:

	March 31, 2021		December 31, 2020
Raw materials	$	15,263	$	15,223
Work-in-process		60,197		61,867
Finished goods		21,084		16,555
Total	$	96,544	$	93,645

Prepayments and Other Current Assets (Tables)

3 Months Ended

Mar. 31, 2021

Prepaid Expense And Other Assets Current [Abstract]

Schedule of Prepayments and Other Current Assets

Prepayments and other current assets are comprised of the following items:

	March 31, 2021		December 31, 2020
Deposits	$	9,285	$	15,976
Prepayments		5,117		6,542
Taxes receivable		16,349		12,122
Total	$	30,751	$	34,640

Investments (Tables)

3 Months Ended

Mar. 31, 2021

Investments Debt And Equity Securities [Abstract]

Summary of Long-term Investments

Long-term investments are comprised of the following items:

	March 31, 2021		December 31, 2020
Equity investments at fair value	$	633	$	477
Equity investments under measurement alternative		11,450		11,392
Debt securities classified under available-for-sale method		—		2,500
Total other investments	$	12,083	$	14,369

Summary of Ownership Interests in Equity Method Investments

	Approximate	Carrying value		Gain (loss) from equity method investments for the three months ended
	ownership %	March 31, 2021		March 31, 2021
Investment in Fluent	50%	$	4,039	$	(1,802	)
Investment in Cannfections	50%		4,061		15
Total equity method investments		$	8,100	$	(1,787	)

	Approximate	Carrying value		Gain (loss) from equity method investments for the three months ended
	ownership %	December 31, 2020		March 31, 2020
Investment in Fluent	50%	$	5,291	$	(1,819	)
Investment in Cannfections	50%		4,009		71
Total equity method investments		$	9,300	$	(1,748	)

Summary of Financial Information for Equity Method Investments

Summary financial information for the equity method investments on an aggregate basis was as follows:

	March 31, 2021		December 31, 2020
Current assets	$	8,440	$	12,644
Noncurrent assets	$	7,033	$	6,608
Current liabilities	$	4,505	$	5,663

	Three months ended March 31,
	2021			2020
Revenue	$	1,061		$	1,392
Gross profit	$	224		$	583
Net loss	$	(3,574	)	$	(3,496	)

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

Allowance For Credit Loss [Abstract]

Allowance for Credit Losses (Tables)

3 Months Ended

Mar. 31, 2021

Schedule of Allowance for Credit Losses

The following table provides activity in the allowance for credit losses for the three months ended March 31, 2021 and March 31, 2020:

	For the three months ended March 31,
	2021			2020
Allowance for credit losses, January 1	$	887		$	615
Provision for expected credit losses ⁽¹⁾		805			46
Write-offs charged against allowance		(439	)		(19	)
Foreign currency translation adjustment		14			(47	)
Allowance for credit losses, March 31	$	1,267		$	595
Accounts receivable balance before allowance for credit losses and provision for sales returns, March 31, 2021 and 2020	$	30,298		$	40,057

(1)	The provision for expected credit losses is recorded in general and administrative expenses

Property and Equipment, Net (Tables)

3 Months Ended

Mar. 31, 2021

Property Plant And Equipment [Abstract]

Summary of Property and Equipment

Property and equipment, net consists of the following:

	March 31, 2021			December 31, 2020
Land	$	6,674		$	6,771
Buildings and leasehold improvements		117,597			117,325
Laboratory and manufacturing equipment		37,254			37,176
Office and computer equipment		2,001			1,710
Right-of-use ("ROU") assets under finance lease		15,270			15,072
Construction-in-process, not yet available for use		49,562			49,380
		228,358			227,434
Less: accumulated depreciation		(30,587	)		(27,875	)
Total	$	197,771		$	199,559

Intangible Assets (Tables)

3 Months Ended

Mar. 31, 2021

Intangible Assets Net Excluding Goodwill [Abstract]

Schedule of Intangible Assets

Intangible assets are comprised of the following items:

			March 31,								December 31,
			2021								2020
	Weighted Average Amortization Period (in years)		Cost		Accumulated Amortization		Impairment		Net		Cost		Accumulated Amortization		Impairment		Net
Definite-lived intangible assets:
Patent		—		—		—		—		—		669		131		538		—
Customer relationships		16		140,709		18,455		—		122,255		138,885		16,030		—		122,855
Developed technology		10		7,322		1,525		—		5,797		7,227		1,325		—		5,902
Websites		3		4,710		3,985		—		725		5,332		4,348		—		984
Trademarks and licenses		5		182		70		—		112		9,009		1,245		7,650		114
Total				152,923		24,035		—		128,889		161,122		23,079		8,188		129,855
Indefinite-lived intangible assets:
Cultivation license	Indefinite			—		—		—		—		10,239		—		10,239		—
Trademarks	Indefinite			57,333		—		—		57,333		56,590		—		—		56,590
Rights under ABG Profit Participation Arrangement	Indefinite			—		—		—		—		16,765		—		16,765		—
Total				57,333		—		—		57,333		83,594		—		27,004		56,590
Total intangible assets			$	210,256	$	24,035	$	—	$	186,222	$	244,716	$	23,079	$	35,192	$	186,445

Schedule of Future Amortization Expenses for Intangible Assets

Expected future amortization expenses for intangible assets as at March 31, 2021 are as follows:

Year ending December 31,	Amortization
2021 (remaining nine months)	$	7,684
2022	$	9,868
2023	$	9,625
2024	$	9,619
2025	$	9,589
Thereafter	$	82,504
Total	$	128,889

Goodwill (Tables)

3 Months Ended

Mar. 31, 2021

Goodwill Disclosure [Abstract]

Schedule of Change in Carrying Amount of Goodwill

The following table shows the change in carrying amount of goodwill:

	Hemp		Cannabis		Total
Balance as of December 31, 2020	$	136,332	$	30,583	$	166,915
Foreign currency translation adjustment		1,762		402		2,164
Balance as of March 31, 2021	$	138,094	$	30,985	$	169,079

Accrued Expenses and Other Current Liabilities (Tables)

3 Months Ended

Mar. 31, 2021

Payables And Accruals [Abstract]

Schedule of Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities are comprised of the following items:

	March 31, 2021		December 31, 2020
Other accrued expenses and current liabilities	$	27,171	$	24,181
Accrued litigation settlement		20,000		—
Accrued payroll and employment related withholding taxes		9,314		9,282
Accrued interest on convertible notes		1,158		3,473
ABG finance liability - current		1,500		1,500
Accrued legal and professional fees		905		1,091
Accrued interest on Senior Facility		413		419
Total accrued expenses and other current liabilities	$	60,461	$	39,946

Convertible Notes (Tables)

3 Months Ended

Mar. 31, 2021

Debt Disclosure [Abstract]

Schedule of Components of Net Carrying Amount of Convertible Notes

The following table sets forth the net carrying amount of the convertible notes:

	March 31, 2021			December 31, 2020
5.00% Convertible Notes	$	277,857		$	277,857
Unamortized discount		(13,977	)		(15,229	)
Unamortized transaction costs		(4,437	)		(4,839	)
Net carrying amount	$	259,443		$	257,789

Schedule of Interest Expenses

The following table sets forth total interest expense recognized related to the convertible notes:

	Three months ended March 31,
	2021		2020
Contractual coupon interest	$	3,473	$	5,938
Amortization of discount		1,253		2,009
Amortization of transaction costs		401		588
Total	$	5,127	$	8,535

Senior Facility (Tables)

3 Months Ended

Mar. 31, 2021

Debt Instrument [Line Items]

Schedule of Components of Net Carrying Amount of Senior Facility

The following table sets forth the net carrying amount of the Senior Facility:

	March 31, 2021			December 31, 2020
Senior Facility	$	51,161		$	50,498
Unamortized transaction costs		(1,614	)		(2,028	)
Net carrying amount	$	49,547		$	48,470
Less: current portion of Senior Facility		(49,547	)		—
Total noncurrent portion of Senior Facility	$	—		$	48,470

Schedule of Interest Expenses

The following table sets forth total interest expense recognized related to the convertible notes:

	Three months ended March 31,
	2021		2020
Contractual coupon interest	$	3,473	$	5,938
Amortization of discount		1,253		2,009
Amortization of transaction costs		401		588
Total	$	5,127	$	8,535

Senior Secured Term Loan Facility [Member]

Debt Instrument [Line Items]

Schedule of Interest Expenses

The following table sets forth total interest expense recognized related to the Senior Facility:

	Three months ended March 31,
	2021		2020
Contractual interest at Canadian prime plus 8.05%	$	1,325	$	480
Amortization of transaction costs		436		131
Total	$	1,761	$	611

Registered Offering and Warrants (Tables)

3 Months Ended

Mar. 31, 2021

Class Of Stock [Line Items]

Schedule of Pre-funded Warrants and Warrants Outstanding

Description

Classification

Exercise

price

Expiration

date

Balance

December 31,

2020

Issued

Exercised

Balance

March 31,

2021

Warrants

Liability

5.95

March 17, 2025

19,000,000

—

12,791,000

6,209,000

Total

19,000,000

—

12,791,000

6,209,000

Schedule of Estimated Fair Value of Warrant Liability

	Quantitative information about Level 3 fair value measurements
	Fair value at March 31, 2021			Valuation technique	Unobservable input	Range (weighted average)

Warrant liability	$	(122,804	)	Monte Carlo	Volatility	100%
					Expected life	0.2 years to 4.5 years (2.1 years)

Warrant [Member]

Class Of Stock [Line Items]

Schedule of Estimated Fair Value of Warrant Liability

The Company estimated the fair value of the Warrant liability at March 31, 2021 using the Monte Carlo pricing model (Level 3) with the following weighted-average assumptions:

Risk-free interest rate		0.92	%
Expected volatility		100	%
Expected term	4.5 years
Expected dividend yield		0	%
Strike price	$	5.95
Fair value of common stock	$	22.73
Discount due to exercise restrictions		0	%

Stockholders' Equity (Tables)

3 Months Ended

Mar. 31, 2021

Summary of Capital Stock

	Par Value		Authorized		Voting Rights
Class 1 common stock	$	0.0001		233,333,333	10 votes for each share
Class 2 common stock	$	0.0001		500,000,000	1 vote for each share
Preferred stock	$	0.0001		10,000,000	N/A

Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section S99
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(27))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

Original Stock Option Plan [Member]

Stock-Based Compensation (Tables)

3 Months Ended

Mar. 31, 2021

Schedule of Stock Option Activity

Stock option activity under the Original Plan is as follows:

	Stock options			Weighted- average exercise price		Weighted- average remaining contractual term (years)		Aggregate intrinsic value
Balance December 31, 2020		1,789,750		$	3.62		3.8	$	25,077
Exercised		(757,318	)		3.17
Forfeited		—			—
Cancelled		(80	)		4.72
Balance March 31, 2021		1,032,352		$	3.93		4.3	$	13,660
Vested and expected to vest, March 31, 2021		986,020		$	3.91		4.3	$	13,618
Vested and exercisable, March 31, 2021		945,951		$	3.72		4.2	$	13,200

2018 Equity Incentive Plan [Member] | Time-based Stock Options [Member]

Schedule of Stock Option Activity

Time-based stock option activity

	Stock options			Weighted- average exercise price		Weighted- average remaining contractual term (years)		Aggregate intrinsic value
Balance December 31, 2020		3,909,559		$	15.25		7.4	$	1,700,194
Granted		—			—
Exercised		(471,211	)		7.76
Forfeited		(33,291	)		8.46
Cancelled		(36,414	)		42.61
Balance March 31, 2021		3,368,643		$	16.02		7.2	$	43,421
Vested and expected to vest, March 31, 2021		3,360,695		$	15.87		7.2	$	43,213
Vested and exercisable, March 31, 2021		2,902,957		$	13.77		7.2	$	38,916

2018 Equity Incentive Plan [Member] | Time-based RSU [Member]

Schedule of RSU Activity

Time-based RSU activity

	Time-based RSUs			Weighted-average grant-date fair value per share
Non-vested December 31, 2020		1,884,390		$	15.22
Granted		350,311			20.02
Vested		(289,388	)		15.59
Forfeited		(170,641	)		11.84
Non-vested March 31, 2021		1,774,672		$	16.33

2018 Equity Incentive Plan [Member] | Performance-based RSUs [Member]

Schedule of RSU Activity

Performance-based RSUs activity

	Performance-based RSUs			Weighted-average grant-date fair value per share
Non-vested December 31, 2020		540,836		$	7.13
Vested		(341,543	)		7.18
Non-vested March 31, 2021		199,293		$	7.05

Accumulated Other Comprehensive (Loss) Income (AOCI) (Tables)

3 Months Ended

Mar. 31, 2021

Schedule of Accumulated Other Comprehensive Income

The component of AOCI, net of tax, was as follows:

	Foreign Currency Translation Adjustments
Balance as at December 31, 2020	$	8,205
Other comprehensive loss:
Change in foreign currency translation		3,753
Balance as at March 31, 2021	$	11,958

Commitments and Contingencies (Tables)

3 Months Ended

Mar. 31, 2021

Commitments And Contingencies Disclosure [Abstract]

Summary of Maturities of Lease Liabilities

Maturities of lease liabilities:

Year ending December 31,	Operating Leases		Finance Leases
2021 (remaining nine months)	$	2,861	$	893
2022		3,498		6,165
2023		3,351		12,438
2024		2,758		—
2025		2,179		—
Thereafter		6,428		—
Total minimum lease payments		21,075		19,496
Less: amounts related to interest payments		3,260		3,902
Present value of minimum lease payments		17,815		15,594
Less: current accrued lease obligation		2,888		—
Obligations recognized	$	14,927	$	15,594

Schedule of Future Non-cancellable Minimum Purchase Commitments

The following table reflects the Company’s future non-cancellable minimum purchase commitments for inventory as of March 31, 2021:

Total

2021

(remaining

nine months)

2022

2023

2024

2025

Thereafter

Purchase commitments

17,359

—

Total

17,359

—

Schedule of Other Commitments Maturities

The Company has payments on the convertible notes (refer to Note 10), the Senior Facility (refer to Note 11), ABG finance liability and Portugal construction purchase commitments as follows:

	Total		2021 (remaining nine months)		2022		2023		2024		2025		Thereafter
Convertible notes, principal and interest	$	319,535	$	13,893	$	13,893	$	291,749	$	—	$	—	$	—
Senior Facility, principal and interest		56,533		4,029		52,504		—		—		—		—
ABG finance liability		7,500		1,500		1,500		1,500		1,500		1,500		—
Portugal construction commitments		2,778		2,778		—		—		—		—		—
Total	$	386,346	$	22,200	$	67,897	$	293,249	$	1,500	$	1,500	$	—

General and Administrative Expenses (Tables)

3 Months Ended

Mar. 31, 2021

General And Administrative Expense [Abstract]

Schedule of General and Administrative Expenses

General and administrative expenses are comprised of the following items:

	Three months ended March 31,
	2021		2020
Other expenses	$	7,613	$	6,848
Salaries and benefits		7,013		7,296
Stock-based compensation expenses		6,493		7,138
Professional fees		3,577		4,521
Credit loss expenses		742		46
Loss on disposal of property and equipment		83		457
Travel expenses		66		963
Total	$	25,587	$	27,269

Supplemental Cash Flow Information (Tables)

3 Months Ended

Mar. 31, 2021

Supplemental Cash Flow Information [Abstract]

Schedule of Supplemental Cash Flow Information

	Three months ended March 31,
	2021		2020
Cash paid for income taxes	$	103	$	—
Cash paid for interest		912		704

Summary of Supplemental Cash Flow Information Related to Leases

	Three months ended March 31,
	2021		2020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	994	$	854
Operating cash flows from finance leases		264		142
Financing cash flows from finance leases		—		105
Non-cash additions to Right-of-use assets and lease liabilities
Operating leases		33		423

Fair Value Measurement (Tables)

3 Months Ended

Mar. 31, 2021

Fair Value Disclosures [Abstract]

Schedule of Assets Measured at Fair Value on Recurring and Non-recurring Basis

	Quoted prices
	in active
	markets for		Other			Significant
	identical		observable			unobservable
	assets		inputs			inputs
	(Level 1)		(Level 2)			(Level 3)			Total
March 31, 2021
Equity investments measured at fair value	$	633	$	—		$	—		$	633
Warrant liability		—		—			(122,804	)		(122,804	)
Convertible Debt		—		(269,223	)		—			(269,223	)
Total recurring fair value measurements	$	633	$	(269,223	)	$	(122,804	)	$	(391,394	)

	Quoted prices
	in active
	markets for		Other			Significant
	identical		observable			unobservable
	assets		inputs			inputs
	(Level 1)		(Level 2)			(Level 3)			Total
December 31, 2020
Investments
Equity investments measured at fair value	$	477	$	—		$	—		$	477
Debt securities classified as available-for-sale		—		—			2,500			2,500
Warrant liability		—		—			(120,647	)		(120,647	)
Convertible Debt		—		(239,652	)		—			(239,652	)
Total recurring fair value measurements	$	477	$	(239,652	)	$	(118,147	)	$	(357,322	)

Schedule of Opening Balances of Assets and Liabilities Categorized Within Level 3 of Fair Value Hierarchy Measured at Fair Value on Recurring Basis are Reconciled to Closing Balances

The opening balances of assets and liabilities categorized within Level 3 of the fair value hierarchy measured at fair value on a recurring basis are reconciled to the closing balances as follows:

	Debt securities classified as available-for- sale			Warrant liability
Opening balance as at December 31, 2020	$	2,500		$	(120,647	)
Additions and settlements
Additions		—			—
Exercise		—			—
Settlements		(2,500	)		81,223
Interest expenses, net		—			—
Change in fair value		—			(83,380	)
Closing balance as at March 31, 2021	$	—		$	(122,804	)

Schedule of Estimated Fair Value of Warrant Liability

	Quantitative information about Level 3 fair value measurements
	Fair value at March 31, 2021			Valuation technique	Unobservable input	Range (weighted average)

Warrant liability	$	(122,804	)	Monte Carlo	Volatility	100%
					Expected life	0.2 years to 4.5 years (2.1 years)

Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.

Summary of Revenue and Gross Profit

Business Segment Information (Tables)

3 Months Ended

Mar. 31, 2021

Segment Reporting [Abstract]

	Three months ended March 31,
	2021				2020
	Revenue		Gross profit		Revenue		Gross profit
Cannabis	$	31,386	$	9,343	$	30,776	$	2,926
Hemp	$	16,635	$	4,160	$	21,326	$	7,944
Total	$	48,021	$	13,503	$	52,102	$	10,870

No asset information is provided for the segments because the Company’s chief operating decision maker does not review this information by segment on a regular basis.

Total revenue and gross profit for the reportable segments is equal to the Company’s consolidated revenue and gross profit.

	Three months ended March 31,
	2021			2020
Gross profit for the segments	$	13,503		$	10,870
General and administrative expenses		25,587			27,269
Sales and marketing expenses		9,739			18,326
Research and development expenses		1,202			1,347
Depreciation and amortization expenses		3,498			3,591
Impairment of assets		—			29,839
Loss from equity method investments		1,787			1,748
Litigation settlement		45,000			—
Foreign exchange (gain) loss, net		(699	)		28,069
Change in fair value of warrant liability		263,201			71,978
Interest expenses, net		6,916			9,146
Other expense (income), net		(1,516	)		4,651
Loss before income taxes	$	(341,212	)	$	(185,094	)

Sources of revenue were as follows:

	Three months ended March 31,
	2021		2020
Dried cannabis	$	21,086	$	19,696
Cannabis extracts		10,270		10,545
Hemp products		16,635		21,326
Accessories and other		30		535
Total	$	48,021	$	52,102

Channels of revenue were as follows:

	Three months ended March 31,
	2021		2020
Cannabis
Adult-use	$	19,440	$	20,919
Canada - medical		3,217		4,051
International - medical		8,600		5,806
Bulk		129		—
Total Cannabis revenue	$	31,386	$	30,776
Hemp		16,635		21,326
Total	$	48,021	$	52,102

Summary of Revenue Attributed to a Geographic Region Based on the Location of the Customer

Revenue attributed to geographic region based on the location of the customer was as follows:

	Three months ended March 31,
	2021		2020
Canada	$	27,195	$	29,488
United States		11,043		16,530
Other countries		9,783		6,084
Total	$	48,021	$	52,102

Summary of Long-lived Assets Consisting of Property and Equipment, Net of Accumulated Depreciation, Attributed to Geographic Regions Based on their Physical Location

Long-lived assets consisting of property and equipment, net of accumulated depreciation, attributed to geographic regions based on their physical location were as follows:

	March 31, 2021		December 31, 2020
Canada	$	122,182	$	122,328
Portugal		69,704		71,988
United States		5,830		5,182
Other countries		55		61
Total	$	197,771	$	199,559

Summary of Significant Accounting Policies - Additional Information (Detail)	3 Months Ended
	Mar. 31, 2021 shares	Mar. 31, 2020 shares	Dec. 15, 2020
Summary Of Significant Accounting Policies [Line Items]
Antidilutive securities excluded from computation of earnings per share	14,243,733	21,266,707
Aphria Inc. [Member] \| Common Stock Class Two [Member]
Summary Of Significant Accounting Policies [Line Items]
Share exchange rate			0.8381

Summary of Significant Accounting Policies - Schedule of Inventory Valuation Adjustments Included in Cost of Sales (Detail) $ in Thousands	3 Months Ended
	Mar. 31, 2020 USD ($)
Inventory Valuation Adjustments [Member]
Inventory [Line Items]
Inventory valuation adjustment no longer disclosed separately from cost of sales	$ 4,044

Summary of Significant Accounting Policies - Summary of Reclassifications of Stock-Based Compensation Expenses (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Share-based compensation expense	$ 6,493	$ 7,138
General and Administrative Expense [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Share-based compensation expense		7,138
Sales and Marketing Expense [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Share-based compensation expense		450
Research and Development Expense [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Share-based compensation expense		$ 89

Inventory - Schedule of Inventory (Detail) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Inventory Disclosure [Abstract]
Raw materials	$ 15,263	$ 15,223
Work-in-process	60,197	61,867
Finished goods	21,084	16,555
Total Inventory	$ 96,544	$ 93,645

Inventory - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cannabis [Member]
Inventory [Line Items]
Inventory write-downs	$ 1,720	$ 3,247
Hemp [Member]
Inventory [Line Items]
Inventory write-downs	$ 342	$ 797

Prepayments and Other Current Assets - Schedule of Prepayments and Other Current Assets (Detail) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Prepaid Expense And Other Assets Current [Abstract]
Deposits	$ 9,285	$ 15,976
Prepayments	5,117	6,542
Taxes receivable	16,349	12,122
Total	$ 30,751	$ 34,640

Investments - Summary of Long-term Investments (Detail) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Investments Debt And Equity Securities [Abstract]
Equity investments at fair value	$ 633	$ 477
Equity investments under measurement alternative	11,450	11,392
Debt securities classified under available-for-sale method		2,500
Total other investments	$ 12,083	$ 14,369

Investments - Additional Information (Detail) - USD ($)	3 Months Ended		12 Months Ended
Investments - Additional Information (Detail) - USD ($)	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Schedule Of Available For Sale Securities [Line Items]
Unrealized gains (loss) on equity Investments	$ 300,000	$ (1,534,000)
Impairments or adjustments equity investments under measurement alternative	0	0
Investment in joint venture under the equity method	8,100,000		$ 9,300,000
Fluent [Member]
Schedule Of Available For Sale Securities [Line Items]
Investment in joint venture under the equity method	4,039,000		5,291,000
Fluent [Member] \| Joint Venture [Member]
Schedule Of Available For Sale Securities [Line Items]
Investment in joint venture under the equity method	493,000	0
Total fees charged	372,000	1,880,000
Fluent [Member] \| Joint Venture [Member] \| Accounts Payable [Member]
Schedule Of Available For Sale Securities [Line Items]
Total fees charged	1,785,000		674,000
Cannfections [Member]
Schedule Of Available For Sale Securities [Line Items]
Investment in joint venture under the equity method	4,061,000		$ 4,009,000
Cannfections [Member] \| Joint Venture [Member]
Schedule Of Available For Sale Securities [Line Items]
Investment in joint venture under the equity method	0	0
Expenses for purchases	448,000	$ 80,000
Convertible Debt Instrument [Member]
Schedule Of Available For Sale Securities [Line Items]
Convertible debt instruments cash settlement amount	$ 2,500,000

Investments - Summary of Ownership Interests in Equity Method Investments (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Schedule Of Equity Method Investments [Line Items]
Carrying value	$ 8,100		$ 9,300
Gain (loss) from equity method investments	$ (1,787)	$ (1,748)
Fluent [Member]
Schedule Of Equity Method Investments [Line Items]
Approximate ownership %	50.00%		50.00%
Carrying value	$ 4,039		$ 5,291
Gain (loss) from equity method investments	$ (1,802)	(1,819)
Cannfections [Member]
Schedule Of Equity Method Investments [Line Items]
Approximate ownership %	50.00%		50.00%
Carrying value	$ 4,061		$ 4,009
Gain (loss) from equity method investments	$ 15	$ 71

Investments - Summary of Financial Information for Equity Method Investments (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Schedule Of Equity Method Investments [Line Items]
Current assets	$ 571,969		$ 347,020
Current liabilities	283,989		181,282
Gross profit	13,503	$ 10,870
Equity Method Investments [Member]
Schedule Of Equity Method Investments [Line Items]
Revenue	1,061	1,392
Gross profit	224	583
Net loss	(3,574)	$ (3,496)
Equity Method Investments [Member] \| Equity Method Investment, Nonconsolidated Investee or Group of Investees [Member]
Schedule Of Equity Method Investments [Line Items]
Current assets	8,440		12,644
Noncurrent assets	7,033		6,608
Current liabilities	$ 4,505		$ 5,663

Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.

Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1,2)
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.

The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 235
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-URI http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 14: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 20: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794

Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 235
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-URI http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(1))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

Allowance for Credit Losses - Schedule of Allowance for Credit Losses (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Allowance For Credit Loss [Abstract]
Allowance for credit losses, January 1	$ 887	$ 615
Provision for expected credit losses	805	46
Write-offs charged against allowance	(439)	(19)
Foreign currency translation adjustment	14	(47)
Allowance for credit losses, March 31	1,267	595
Accounts receivable balance before allowance for credit losses and provision for sales returns, March 31, 2021 and 2020	$ 30,298	$ 40,057

Property and Equipment, Net - Summary of Property and Equipment (Detail) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Property Plant And Equipment [Line Items]
Property and equipment, gross	$ 228,358	$ 227,434
Less: accumulated depreciation	(30,587)	(27,875)
Total	197,771	199,559
Land [Member]
Property Plant And Equipment [Line Items]
Property and equipment, gross	6,674	6,771
Buildings and Leasehold Improvements [Member]
Property Plant And Equipment [Line Items]
Property and equipment, gross	117,597	117,325
Laboratory and Manufacturing Equipment [Member]
Property Plant And Equipment [Line Items]
Property and equipment, gross	37,254	37,176
Office and Computer Equipment [Member]
Property Plant And Equipment [Line Items]
Property and equipment, gross	2,001	1,710
Right-of-Use ("ROU") Assets Under Finance Lease [Member]
Property Plant And Equipment [Line Items]
Property and equipment, gross	15,270	15,072
Construction-in-Process, Not Yet Available for Use [Member]
Property Plant And Equipment [Line Items]
Property and equipment, gross	$ 49,562	$ 49,380

Intangible Assets - Schedule of Intangible Assets (Detail) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Finite and Indefinite Lived Intangible Assets [Line Items]
Definite-lived intangible asset, Cost	$ 152,923	$ 161,122
Definite-lived intangible asset, Accumulated Amortization	24,035	23,079
Definite-lived intangible asset, Impairment		8,188
Definite-lived intangible asset, Net	128,889	129,855
Indefinite-lived intangible asset, Cost	57,333	83,594
Indefinite-lived intangible asset, Impairment		27,004
Indefinite-lived intangible asset, Net	57,333	56,590
Total intangible asset, Cost	210,256	244,716
Total intangible asset, Impairment		35,192
Total intangible asset, Net	$ 186,222	186,445
Patents [Member]
Finite and Indefinite Lived Intangible Assets [Line Items]
Definite-lived intangible asset, Cost		669
Definite-lived intangible asset, Accumulated Amortization		131
Definite-lived intangible asset, Impairment		538
Customer Relationships [Member]
Finite and Indefinite Lived Intangible Assets [Line Items]
Weighted Average Amortization Period (in years)	16 years
Definite-lived intangible asset, Cost	$ 140,709	138,885
Definite-lived intangible asset, Accumulated Amortization	18,455	16,030
Definite-lived intangible asset, Net	$ 122,255	122,855
Developed Technology [Member]
Finite and Indefinite Lived Intangible Assets [Line Items]
Weighted Average Amortization Period (in years)	10 years
Definite-lived intangible asset, Cost	$ 7,322	7,227
Definite-lived intangible asset, Accumulated Amortization	1,525	1,325
Definite-lived intangible asset, Net	$ 5,797	5,902
Websites [Member]
Finite and Indefinite Lived Intangible Assets [Line Items]
Weighted Average Amortization Period (in years)	3 years
Definite-lived intangible asset, Cost	$ 4,710	5,332
Definite-lived intangible asset, Accumulated Amortization	3,985	4,348
Definite-lived intangible asset, Net	$ 725	984
Trademarks and Licenses [Member]
Finite and Indefinite Lived Intangible Assets [Line Items]
Weighted Average Amortization Period (in years)	5 years
Definite-lived intangible asset, Cost	$ 182	9,009
Definite-lived intangible asset, Accumulated Amortization	70	1,245
Definite-lived intangible asset, Impairment		7,650
Definite-lived intangible asset, Net	$ 112	114
Cultivation License [Member]
Finite and Indefinite Lived Intangible Assets [Line Items]
Weighted Average Amortization Period (in years)	Indefinite
Indefinite-lived intangible asset, Cost		10,239
Indefinite-lived intangible asset, Impairment		10,239
Trademarks [Member]
Finite and Indefinite Lived Intangible Assets [Line Items]
Weighted Average Amortization Period (in years)	Indefinite
Indefinite-lived intangible asset, Cost	$ 57,333	56,590
Indefinite-lived intangible asset, Net	$ 57,333	56,590
Rights under ABG Profit Participation Arrangement [Member]
Finite and Indefinite Lived Intangible Assets [Line Items]
Weighted Average Amortization Period (in years)	Indefinite
Indefinite-lived intangible asset, Cost		16,765
Indefinite-lived intangible asset, Impairment		$ 16,765

Intangible Assets - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Goodwill And Intangible Assets Disclosure [Abstract]
Amortization expenses for intangible assets	$ 2,271	$ 1,857

Intangible Assets - Schedule of Future Amortization Expenses for Intangible Assets (Detail) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Finite Lived Intangible Assets Future Amortization Expense [Abstract]
2021 (remaining nine months)	$ 7,684
2022	9,868
2023	9,625
2024	9,619
2025	9,589
Thereafter	82,504
Definite-lived intangible asset, Net	$ 128,889	$ 129,855

Goodwill - Schedule of Change in Carrying Amount of Goodwill (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2021 USD ($)
Goodwill [Line Items]
Balance as of December 31, 2020	$ 166,915
Foreign currency translation adjustment	2,164
Balance as of March 31, 2021	169,079
Hemp [Member]
Goodwill [Line Items]
Balance as of December 31, 2020	136,332
Foreign currency translation adjustment	1,762
Balance as of March 31, 2021	138,094
Cannabis [Member]
Goodwill [Line Items]
Balance as of December 31, 2020	30,583
Foreign currency translation adjustment	402
Balance as of March 31, 2021	$ 30,985

Accrued Expenses and Other Current Liabilities - Summary of Accrued Expenses and Other Current Liabilities (Detail) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Accounts Payable Accrued Liabilities And Other Current Liabilities [Line Items]
Other accrued expenses and current liabilities	$ 27,171	$ 24,181
Accrued litigation settlement	20,000
Accrued payroll and employment related withholding taxes	9,314	9,282
Accrued interest on convertible notes	1,158	3,473
Accrued legal and professional fees	905	1,091
Accrued interest on Senior Facility	413	419
Total accrued expenses and other current liabilities	60,461	39,946
ABG [Member]
Accounts Payable Accrued Liabilities And Other Current Liabilities [Line Items]
ABG finance liability - current	$ 1,500	$ 1,500

Convertible Notes - Additional Information (Detail) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Convertible Senior Notes Due 2023 [Member]
Debt Instrument [Line Items]
Debt instrument, face amount	$ 277,857	$ 277,857

Convertible Notes - Schedule of Components of Net Carrying Amount of Convertible Notes (Detail) - Convertible Senior Notes Due 2023 [Member] - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Debt Instrument [Line Items]
5.00% Convertible Notes	$ 277,857	$ 277,857
Unamortized discount	(13,977)	(15,229)
Unamortized transaction costs	(4,437)	(4,839)
Net carrying amount	$ 259,443	$ 257,789

Convertible Notes - Schedule of Interest Expense Schedule of Interest Expense Related to Convertible Notes (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Debt Instrument [Line Items]
Amortization of discount	$ 1,653	$ 2,597
Convertible Senior Notes Due 2023 [Member]
Debt Instrument [Line Items]
Contractual coupon interest	3,473	5,938
Amortization of discount	1,253	2,009
Amortization of transaction costs	401	588
Total	$ 5,127	$ 8,535

Senior Facility - Additional Information (Detail)			3 Months Ended
Senior Facility - Additional Information (Detail)	Jun. 05, 2020	Feb. 28, 2020 USD ($)	Mar. 31, 2021	Mar. 31, 2020	Feb. 28, 2020 CAD ($)
Line Of Credit Facility [Line Items]
Canadian prime rate			8.05%
Senior Secured Term Loan Facility [Member]
Line Of Credit Facility [Line Items]
Canadian prime rate				8.05%
Senior Secured Term Loan Facility [Member] \| High Park Holdings, Ltd. [Member]
Line Of Credit Facility [Line Items]
Maximum aggregate principal amount		$ 59,600,000			$ 79,800,000
Canadian prime rate		8.05%
Frequency of payment and payment terms			The Company has the option to voluntarily prepay, without penalty, the outstanding amounts, in full or in part, at any time starting 6 months from the closing date subsequent to providing 75 days’ notice.
Minimum unrestricted cash threshold for capital expenditures and investments		$ 29,466,000			$ 40,000,000
Senior Secured Term Loan Facility Amendment [Member]
Line Of Credit Facility [Line Items]
Line of credit facility, expiration date	Feb. 28, 2022

Senior Facility - Schedule of Components of Net Carrying Amount of Senior Facility (Detail) - Senior Secured Term Loan Facility [Member] - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Debt Instrument [Line Items]
Debt instrument, face amount	$ 51,161	$ 50,498
Unamortized transaction costs	(1,614)	(2,028)
Net carrying amount	49,547	48,470
Less: current portion of Senior Facility	$ (49,547)
Total noncurrent portion of Senior Facility		$ 48,470

Senior Facility - Schedule of Interest Expenses Recognized Related to Senior Facility (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Debt Instrument [Line Items]
Amortization of discount on convertible notes	$ 1,653	$ 2,597
Senior Secured Term Loan Facility [Member]
Debt Instrument [Line Items]
Contractual interest at Canadian prime plus 8.05%	1,325	480
Amortization of discount on convertible notes	436	131
Total	$ 1,761	$ 611

Senior Facility - Schedule of Interest Expenses Recognized Related to Senior Facility (Parenthetical) (Detail)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Debt Instrument [Line Items]
Canadian prime rate	8.05%
Senior Secured Term Loan Facility [Member]
Debt Instrument [Line Items]
Canadian prime rate		8.05%

Registered Offering and Warrants - Schedule of Pre-funded Warrants and Warrants Outstanding (Detail)	3 Months Ended
	Mar. 31, 2021 $ / shares shares
Class Of Warrant Or Right [Line Items]
Beginning Balance	19,000,000
Warrant exercised	12,791,000
Ending Balance	6,209,000
Warrants [Member]
Class Of Warrant Or Right [Line Items]
Warrant description	Warrants
Warrant classification	Liability
Warrant exercise price \| $ / shares	$ 5.95
Warrant expiration date	Mar. 17, 2025
Beginning Balance	19,000,000
Warrant exercised	12,791,000
Ending Balance	6,209,000

Registered Offering and Warrants - Additional Information (Detail) $ in Thousands	3 Months Ended
	Mar. 31, 2021 USD ($) shares
Class Of Stock [Line Items]
Warrants were exercised by warrant holders \| shares	12,791,000
Proceeds from exercise of warrants \| $	$ 76,106
Warrants [Member]
Class Of Stock [Line Items]
Warrants were exercised by warrant holders \| shares	12,791,000
Proceeds from exercise of warrants \| $	$ 76,106

Registered Offering and Warrants - Schedule of Estimated Fair Value of Warrant Liability (Detail) - Warrant [Member] - Level 3 [Member]	Mar. 31, 2021 USD ($) yr
Risk-Free Interest Rate [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrant and rights measurement input	0.0092
Expected Volatility [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrant and rights measurement input	1
Expected Term [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrant and rights measurement input \| yr	4.5
Expected Dividend Yield [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrant and rights measurement input	0
Strike Price [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrant and rights measurement input	5.95
Fair Value of Common Stock [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrant and rights measurement input	22.73
Discount Due to Exercise Restrictions [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Warrant and rights measurement input	0

Stockholders' Equity - Summary of Capital Stock (Detail)	3 Months Ended
	Mar. 31, 2021 $ / shares shares
Class 1 Common Stock [Member]
Class Of Stock [Line Items]
Common stock, par value \| $ / shares	$ 0.0001
Common stock, shares authorized \| shares	233,333,333
Common stock voting rights	10 votes for each share
Common Stock Class Two [Member]
Class Of Stock [Line Items]
Common stock, par value \| $ / shares	$ 0.0001
Common stock, shares authorized \| shares	500,000,000
Common stock voting rights	1 vote for each share
Preferred Stock [Member]
Class Of Stock [Line Items]
Convertible preferred stock \| $ / shares	$ 0.0001
Convertible preferred stock shares authorized \| shares	10,000,000
Convertible preferred stock voting rights	N/A

Stockholders' Equity - Summary of Capital Stock (Parenthetical) (Detail)	Mar. 31, 2021 Vote
Class 1 Common Stock [Member]
Class Of Stock [Line Items]
Common stock, votes for each share	10
Common Stock Class Two [Member]
Class Of Stock [Line Items]
Common stock, votes for each share	1

Stockholders' Equity - Additional Information (Detail) - Common Stock Class Two [Member] - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Class Of Stock [Line Items]
Common stock issued, Shares	6,254,980
Proceeds from issuance of common stock, gross	$ 159,213,000	$ 27,579,000
Transaction costs recorded net against allocated gross proceeds in additional paid-in-capital	3,184,000
Maximum allowed aggregate gross proceeds from share issuance under ATM program	20,000,000
Maximum amount of share issuance allowed per quarter	$ 6,000,000

Stock-Based Compensation - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Allocated share-based compensation expenses	$ 6,493	$ 7,138
Original Stock Option Plan [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Allocated share-based compensation expenses	57	$ 162
Unrecognized compensation expenses	$ 193
Unrecognized stock-based compensation expense to be recognized in period, years	7 months 6 days
Stock options granted	0	0
Fair values of stock option vested	$ 61	$ 169
2018 Equity Incentive Plan [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Allocated share-based compensation expenses	7,084	7,515
Unrecognized compensation expenses	$ 29,883
Unrecognized stock-based compensation expense to be recognized in period, years	1 year 7 months 17 days
2018 Equity Incentive Plan [Member] \| Time-based Stock Options [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Fair values of stock option vested	$ 2,547	$ 25,426
Weighted average fair values of stock options granted, per share	$ 0	$ 0
2018 Equity Incentive Plan [Member] \| Time-based RSU [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of RSUs granted	350,311	752,283
Number of RSUs vested	289,388	154,642
2018 Equity Incentive Plan [Member] \| Performance-based RSUs [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of RSUs granted	0	0
Number of RSUs vested	341,543	53,125
2018 Equity Incentive Plan [Member] \| Class 2 common stock [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Common shares reserved for issuance, annual automatic increase percentage	4.00%
2018 Equity Incentive Plan [Member] \| Class 2 common stock [Member] \| Maximum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of common stock reserved for issuance, term	10 years
2018 Equity Incentive Plan [Member] \| Class 2 common stock [Member] \| Stock Options and Restricted Stock Units [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares are reserved for issuance	23,375,665		17,037,421

Stock-Based Compensation - Schedule of Stock Option Activity (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Original Stock Option Plan [Member]
Stock options
Shares, Beginning Balance	1,789,750
Shares, Granted	0	0
Shares, Exercised	(757,318)
Shares, Cancelled	(80)
Shares, Ending Balance	1,032,352		1,789,750
Shares, Vested and expected to vest	986,020
Shares, Vested and exercisable	945,951
Weighted-average exercise price
Weighted-average exercise price, Beginning Balance	$ 3.62
Weighted-average exercise price, Exercised	3.17
Weighted-average exercise price, Cancelled	4.72
Weighted-average exercise price, Ending Balance	3.93		$ 3.62
Weighted-average exercise price, Vested and expected to vest	3.91
Weighted-average exercise price, Vested and exercisable	$ 3.72
Weighted-average remaining contractual term (years)
Weighted-average remaining contractual term	4 years 3 months 18 days		3 years 9 months 18 days
Weighted-average remaining contractual term, Vested and expected to vest	4 years 3 months 18 days
Weighted-average remaining contractual term, Vested and exercisable	4 years 2 months 12 days
Aggregate intrinsic value
Aggregate intrinsic value	$ 13,660		$ 25,077
Aggregate intrinsic value, Vested and expected to vest	13,618
Aggregate intrinsic value, Vested and exercisable	$ 13,200
2018 Equity Incentive Plan [Member] \| Time-based Stock Options [Member]
Stock options
Shares, Beginning Balance	3,909,559
Shares, Exercised	(471,211)
Shares, Forfeited	(33,291)
Shares, Cancelled	(36,414)
Shares, Ending Balance	3,368,643		3,909,559
Shares, Vested and expected to vest	3,360,695
Shares, Vested and exercisable	2,902,957
Weighted-average exercise price
Weighted-average exercise price, Beginning Balance	$ 15.25
Weighted-average exercise price, Exercised	7.76
Weighted-average exercise price, Forfeited	8.46
Weighted-average exercise price, Cancelled	42.61
Weighted-average exercise price, Ending Balance	16.02		$ 15.25
Weighted-average exercise price, Vested and expected to vest	15.87
Weighted-average exercise price, Vested and exercisable	$ 13.77
Weighted-average remaining contractual term (years)
Weighted-average remaining contractual term	7 years 2 months 12 days		7 years 4 months 24 days
Weighted-average remaining contractual term, Vested and expected to vest	7 years 2 months 12 days
Weighted-average remaining contractual term, Vested and exercisable	7 years 2 months 12 days
Aggregate intrinsic value
Aggregate intrinsic value	$ 43,421		$ 1,700,194
Aggregate intrinsic value, Vested and expected to vest	43,213
Aggregate intrinsic value, Vested and exercisable	$ 38,916

Stock-based Compensation - Schedule of RSU Activity (Detail) - 2018 Equity Incentive Plan [Member] - $ / shares	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Time-based RSU [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share equivalent, Beginning Balance	1,884,390
Share equivalent, Granted	350,311	752,283
Share equivalent, Vested	(289,388)	(154,642)
Share equivalent, Forfeited	(170,641)
Share equivalent, Ending Balance	1,774,672
Weighted-average grant date fair value, Beginning Balance	$ 15.22
Weighted-average grant date fair value, Granted	20.02
Weighted-average grant date fair value, Vested	15.59
Weighted-average grant date fair value, Forfeited	11.84
Weighted-average grant date fair value, Ending Balance	$ 16.33
Performance-based RSUs [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share equivalent, Beginning Balance	540,836
Share equivalent, Granted	0	0
Share equivalent, Vested	(341,543)	(53,125)
Share equivalent, Ending Balance	199,293
Weighted-average grant date fair value, Beginning Balance	$ 7.13
Weighted-average grant date fair value, Vested	7.18
Weighted-average grant date fair value, Ending Balance	$ 7.05

Accumulated Other Comprehensive (Loss) Income ("AOCI") - Schedule of Accumulated Other Comprehensive Income (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning balance	$ 8,205
Change in foreign currency translation	3,753	$ (16,633)
Ending balance	11,958
Foreign Currency Translation Adjustments [Member]
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning balance	8,205
Change in foreign currency translation	3,753
Ending balance	$ 11,958

Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.

Commitments and Contingencies - Summary of Maturities of Lease Liabilities (Detail) $ in Thousands	Mar. 31, 2021 USD ($)
Operating leases
2021 (remaining nine months)	$ 2,861
2022	3,498
2023	3,351
2024	2,758
2025	2,179
Thereafter	6,428
Total minimum lease payments	21,075
Less: amounts related to interest payments	3,260
Present value of minimum lease payments	17,815
Less: current accrued lease obligation	2,888
Obligations recognized	$ 14,927
Operating Lease, Liability, Statement of Financial Position [Extensible List]	tlry:OperatingLeaseLiabilityMember
Finance leases
2021 (remaining nine months)	$ 893
2022	6,165
2023	12,438
Total minimum lease payments	19,496
Less: amounts related to interest payments	3,902
Present value of minimum lease payments	15,594
Obligations recognized	$ 15,594
Finance Lease Liability Statement Of Financial Position Extensible List	tlry:FinanceLeaseLiabilityMember

Commitments and Contingencies - Schedule of Future Non-cancellable Minimum Purchase Commitments (Detail) $ in Thousands	Mar. 31, 2021 USD ($)
Purchase Commitment Excluding Longterm Commitment [Line Items]
Total	$ 17,359
2021 (remaining nine months)	17,359
Purchase Commitments [Member]
Purchase Commitment Excluding Longterm Commitment [Line Items]
Total	17,359
2021 (remaining nine months)	$ 17,359

Commitments and Contingencies - Additional Information (Detail) - USD ($)	1 Months Ended	3 Months Ended		12 Months Ended
	Sep. 30, 2020	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2018
Docklight LLC [Member] \| General and Administrative Expense [Member]
Long Term Purchase Commitment [Line Items]
Management service fees expense		$ 493,000	$ 221,000
Rose Lifescience, Inc [Member]
Long Term Purchase Commitment [Line Items]
Estimated compensation fee	$ 8,000,000
Firm commission fee commitment excluded		0
Rose Lifescience, Inc [Member] \| Distribution and Marketing [Member]
Long Term Purchase Commitment [Line Items]
Commitment Term				5 years
Rose Lifescience, Inc [Member] \| Distribution and Marketing [Member] \| Minimum [Member]
Long Term Purchase Commitment [Line Items]
Minimum commitment Fee				$ 384,000
Supply Agreement [Member]
Long Term Purchase Commitment [Line Items]
Purchase commitments removed amount		$ 59,700,000
Product and Trademark License Agreement [Member] \| Docklight LLC [Member] \| General and Administrative Expense [Member]
Long Term Purchase Commitment [Line Items]
Management service fees expense				$ 493,000

Commitments and Contingencies - Schedule of Other Commitments Maturities (Detail) $ in Thousands	Mar. 31, 2021 USD ($)
Other Commitments [Line Items]
Total	$ 386,346
2021 (remaining nine months)	22,200
2022	67,897
2023	293,249
2024	1,500
2025	1,500
Convertible Notes, Principal and Interest [Member]
Other Commitments [Line Items]
Total	319,535
2021 (remaining nine months)	13,893
2022	13,893
2023	291,749
Senior Facility, Principal and Interest [Member]
Other Commitments [Line Items]
Total	56,533
2021 (remaining nine months)	4,029
2022	52,504
ABG Finance Liability [Member]
Other Commitments [Line Items]
Total	7,500
2021 (remaining nine months)	1,500
2022	1,500
2023	1,500
2024	1,500
2025	1,500
Portugal Construction Commitments [Member]
Other Commitments [Line Items]
Total	2,778
2021 (remaining nine months)	$ 2,778

Revenue from Contracts with Customers (Detail)	3 Months Ended
Revenue from Contracts with Customers (Detail)	Mar. 31, 2021 USD ($) Segment	Dec. 31, 2020 USD ($)
Revenue From Contract With Customer [Abstract]
Number of reportable segments \| Segment	2
Contract balances in the balance sheets \| $	$ 0	$ 0

General and Administrative Expenses - Schedule of General and Administrative Expenses (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
General And Administrative Expense [Abstract]
Other expenses	$ 7,613	$ 6,848
Salaries and benefits	7,013	7,296
Stock-based compensation expenses	6,493	7,138
Professional fees	3,577	4,521
Credit loss expenses	742	46
Loss on disposal of property and equipment	83	457
Travel expenses	66	963
Total	$ 25,587	$ 27,269

Supplemental Cash Flow Information - Schedule of Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Supplemental Cash Flow Information [Abstract]
Cash paid for income taxes	$ 103
Cash paid for interest	$ 912	$ 704

Supplemental Cash Flow Information - Summary of Supplemental Cash Flow Information Related to Leases (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$ 994	$ 854
Operating cash flows from finance leases	264	142
Financing cash flows from finance leases		105
Non-cash additions to Right-of-use assets and lease liabilities
Operating leases	$ 33	$ 423

Related Party Transactions - Additional Information (Detail) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Cannfections [Member]
Related Party Transaction [Line Items]
Percentage of ownership	50.00%		50.00%
Fluent [Member]
Related Party Transaction [Line Items]
Percentage of ownership	50.00%		50.00%
Joint Venture [Member] \| Cannfections [Member]
Related Party Transaction [Line Items]
Percentage of ownership	50.00%
Percentage of voting interest	50.00%
Joint Venture [Member] \| Fluent [Member]
Related Party Transaction [Line Items]
Percentage of ownership	50.00%
Percentage of voting interest	50.00%
General and Administrative Expense [Member] \| Leafly Holdings, Inc [Member]
Related Party Transaction [Line Items]
Operational expenses	$ 0	$ 129,000
General and Administrative Expense [Member] \| Docklight LLC [Member]
Related Party Transaction [Line Items]
Management service fees expense	$ 493,000	$ 221,000

Financial Instruments - Additional Information (Detail) $ in Thousands	3 Months Ended
	Mar. 31, 2021 USD ($)
Financial Instruments [Abstract]
Change in exchange rate	10.00%
Carrying value of net asset	$ 47,220
Canadian prime rate	8.05%
Convertible notes, fixed interest rate	5.00%
Change in Canadian prime rate	1.00%
Loss due to one percentage change in Canadian prime rate	$ 134
Hypothetical decrease in fair value of investments	10.00%
Estimated decrease in fair values of investments upon hypothetical decrease of 10% in the prices	$ 1,132
Hypothetical increase in common stock	10.00%
Estimated increase in fair values of warrant liability upon hypothetical increase of 10% in the price of common stock	$ 12,290

Fair Value Measurement - Schedule of Assets Measured Fair Value on Recurring Basis (Detail) - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Fair Value, Measurements, Recurring [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Warrant liability	$ (122,804,000)	$ (120,647,000)
Convertible Debt	(269,223,000)	(239,652,000)
Total recurring fair value measurements	(391,394,000)	(357,322,000)
Fair Value, Measurements, Recurring [Member] \| Equity Investments Measured at Fair Value [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Total investments	633,000	477,000
Fair Value, Measurements, Recurring [Member] \| Debt Securities Classified as Available-for-Sale [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Total investments		2,500,000
Level 1 [Member] \| Fair Value, Measurements, Recurring [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Total recurring fair value measurements	633,000	477,000
Level 1 [Member] \| Fair Value, Measurements, Recurring [Member] \| Equity Investments Measured at Fair Value [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Total investments	633,000	477,000
Level 2 [Member] \| Fair Value, Measurements, Recurring [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Convertible Debt	(269,223,000)	(239,652,000)
Total recurring fair value measurements	(269,223,000)	(239,652,000)
Level 3 [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Warrant liability	(122,804)
Level 3 [Member] \| Fair Value, Measurements, Recurring [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Warrant liability	(122,804,000)	(120,647,000)
Total recurring fair value measurements	$ (122,804,000)	(118,147,000)
Level 3 [Member] \| Fair Value, Measurements, Recurring [Member] \| Debt Securities Classified as Available-for-Sale [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Total investments		$ 2,500,000

Fair Value Measurement - Summary of Opening Balances of Assets and Liabilities Categorized Within Level 3 of the Fair Value Hierarchy Measured at Fair Value on a Recurring Basis (Detail) $ in Thousands	3 Months Ended
	Mar. 31, 2021 USD ($)
Fair Value Disclosures [Abstract]
Debt securities classified as available-for-sale, Beginning Balance	$ 2,500
Debt securities classified as available-for-sale, Settlements	(2,500)
Warrant liability, Beginning Balance	(120,647)
Warrant liability, Settlements	81,223
Warrant liability, Change in fair value	(83,380)
Warrant liability, Ending Balance	$ (122,804)

Fair Value Measurement - Summary of Quantitative Information about Level 3 Fair Value Measurements (Detail) - Quantitative information about Level 3 Fair Value Measurements [Member]	Mar. 31, 2021 USD ($) yr
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Warrant liability \| $	$ (122,804)
Warrants and Rights Outstanding, Valuation Technique [Extensible List]	tlry:ValuationTechniqueMonteCarloMember
Volatility [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Warrant and rights measurement input	100
Minimum [Member] \| Expected Term [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Warrant and rights measurement input	0.2
Maximum [Member] \| Expected Term [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Warrant and rights measurement input	4.5
Weighted Average [Member] \| Expected Term [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Warrant and rights measurement input	2.1

Business Segment Information - Additional Information (Detail)	3 Months Ended		12 Months Ended
	Mar. 31, 2021 USD ($) Segment	Mar. 31, 2020 USD ($)	Dec. 31, 2020
Segment Reporting Information [Line Items]
Number of operating segment \| Segment	2
Revenue	$ 48,021,000	$ 52,102,000
Excise duties	$ 4,646,000	$ 4,972,000
Customer Concentration Risk [Member] \| Revenue [Member] \| Cannabis Reportable Segment [Member] \| Customer A [Member]
Segment Reporting Information [Line Items]
Concentration risk percentage	20.00%	16.00%
Customer Concentration Risk [Member] \| Revenue [Member] \| Cannabis Reportable Segment [Member] \| Customer B [Member]
Segment Reporting Information [Line Items]
Concentration risk percentage		13.00%
Customer Concentration Risk [Member] \| Revenue [Member] \| Hemp Reportable Segment [Member] \| Customer A [Member]
Segment Reporting Information [Line Items]
Concentration risk percentage	11.00%	26.00%
Customer Concentration Risk [Member] \| Accounts Receivable [Member] \| Customer A [Member]
Segment Reporting Information [Line Items]
Concentration risk percentage	18.00%		17.00%
Customer Concentration Risk [Member] \| Accounts Receivable [Member] \| Customer B [Member]
Segment Reporting Information [Line Items]
Concentration risk percentage	11.00%		16.00%
Customer Concentration Risk [Member] \| Accounts Receivable [Member] \| Customer C [Member]
Segment Reporting Information [Line Items]
Concentration risk percentage			11.00%
Intersegment Sales or Transfers [Member]
Segment Reporting Information [Line Items]
Revenue	$ 0

Business Segment Information - Summary of Revenue and Gross Profit of each Segment (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Segment Reporting Information [Line Items]
Revenue	$ 48,021	$ 52,102
Gross profit	13,503	10,870
Cannabis [Member]
Segment Reporting Information [Line Items]
Revenue	31,386	30,776
Gross profit	9,343	2,926
Hemp [Member]
Segment Reporting Information [Line Items]
Revenue	16,635	21,326
Gross profit	$ 4,160	$ 7,944

Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.

Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 924
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-URI http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856

Business Segment Information - Summary of Revenue and Gross Profit (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Segment Reporting [Abstract]
Gross profit for the segments	$ 13,503	$ 10,870
General and administrative expenses	25,587	27,269
Sales and marketing expenses	9,739	18,326
Research and development expenses	1,202	1,347
Depreciation and amortization expenses	3,498	3,591
Impairment of assets		29,839
Loss from equity method investments	1,787	1,748
Litigation settlement	45,000
Foreign exchange (gain) loss, net	(699)	28,069
Change in fair value of warrant liability	263,201	71,978
Interest expenses, net	6,916	9,146
Other (income) expenses, net	(1,516)	4,651
Loss before income taxes	$ (341,212)	$ (185,094)

Business Segment Information - Summary of Sources of Revenue (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Segment Reporting Information [Line Items]
Revenue	$ 48,021	$ 52,102
Dried Cannabis [Member]
Segment Reporting Information [Line Items]
Revenue	21,086	19,696
Cannabis Extracts [Member]
Segment Reporting Information [Line Items]
Revenue	10,270	10,545
Hemp Products [Member]
Segment Reporting Information [Line Items]
Revenue	16,635	21,326
Accessories And Other [Member]
Segment Reporting Information [Line Items]
Revenue	$ 30	$ 535

Business Segment Information - Summary of Channels of Revenue (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Segment Reporting Information [Line Items]
Revenue	$ 48,021	$ 52,102
Cannabis [Member]
Segment Reporting Information [Line Items]
Revenue	31,386	30,776
Cannabis [Member] \| Adult-use [Member]
Segment Reporting Information [Line Items]
Revenue	19,440	20,919
Cannabis [Member] \| Canada - medical [Member]
Segment Reporting Information [Line Items]
Revenue	3,217	4,051
Cannabis [Member] \| International - medical [Member]
Segment Reporting Information [Line Items]
Revenue	8,600	5,806
Cannabis [Member] \| Bulk [Member]
Segment Reporting Information [Line Items]
Revenue	129
Hemp [Member]
Segment Reporting Information [Line Items]
Revenue	$ 16,635	$ 21,326

Business Segment Information - Summary of Revenues Attributed to a Geographic Region Based on the Location of the Customer (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Segment Reporting Information [Line Items]
Revenues	$ 48,021	$ 52,102
CANADA [Member]
Segment Reporting Information [Line Items]
Revenues	27,195	29,488
UNITED STATES [Member]
Segment Reporting Information [Line Items]
Revenues	11,043	16,530
Other Countries [Member]
Segment Reporting Information [Line Items]
Revenues	$ 9,783	$ 6,084